Research & Innovation
Published on
July 24, 2023

A Revolution in the Treatment of Cardiovascular Disorders

photobiomodulation treatment for cardiovascular disorders

Share this article:

In short: Photobiomodulation is a noninvasive method that converts light energy from low-intensity LEDs or lasers into cellular energy to stimulate tissue repair. When applied to cardiovascular disorders, it may reduce infarct size, improve cardiac function through enhanced mitochondrial activity, lower blood pressure, and promote peripheral circulation. However, standardized protocols and further clinical trials are still needed to confirm its effectiveness.

Photobiomodulation: A Revolution in the Treatment of Cardiovascular Disorders

Introduction to Photobiomodulation

Photobiomodulation (PBM), also known as low-level laser therapy, is a noninvasive medical method. It is gaining popularity and could revolutionize the treatment of cardiovascular disorders, a leading cause of death worldwide.

Understanding Photobiomodulation

Photobiomodulation uses low-intensity lasers or LEDs to stimulate the healing of damaged or diseased tissue. This technique converts light energy into cellular energy, triggering beneficial biological responses.

The mechanisms of action of photobiomodulation on mitochondrial cells

The Potential of Photobiomodulation for Cardiovascular Disorders¹

PBM holds promise as a new treatment strategy for several cardiovascular disorders, such as:

  • Ischemic heart disease: It may reduce the size of the heart attack by improving blood flow to the heart tissue.
  • Heart Failure: Research shows an improvement in cardiac function, attributed to improved mitochondrial function and a reduction in oxidative stress.
  • High Blood Pressure: PBM can lower blood pressure by improving endothelial function and reducing oxidative stress.
  • Peripheral Artery Disease: This therapy may improve blood flow in the peripheral arteries, thereby relieving symptoms.

Challenges and Future Prospects

Despite its potential, photobiomodulation faces challenges such as the need to standardize treatment protocols and conduct more clinical trials to confirm its effectiveness.

Photobiomodulation is a promising therapeutic approach that could revolutionize the treatment of cardiovascular disorders. Although further research is needed to refine its mechanism of action and establish standardized protocols, PBM is poised to become a major breakthrough in cardiovascular medicine.

Reference: ¹ Exploring the Potential of Energy-Based Therapeutics (Photobiomodulation/Low-Level Laser Light Therapy) in Cardiovascular Disorders: A Review and Perspective

See also

Our News

Similar articles, tips, and discoveries

All the latest news
Research & Innovation
Photobiomodulation Research Update - June 2026
Our summary of the 58 publications on photobiomodulation that were published or indexed in June 2026. Topics include: oral mucositis confirmed by a multicenter randomized trial; PBM for pain associated with temporomandibular disorders; and more recent research in cognition, sleep, and presbyopia.
Read the article
Research & Innovation
Photobiomodulation and Chemotherapy: The Study That Restores Memory
A study by the Valenciennes Hospital (CHV) confirms that transcranial photobiomodulation (using the Vielight Duo 4 headset) restores memory after chemotherapy: 93.5% of patients showed improvement.
Read the article
Research & Innovation
Photobiomodulation Research Update - May 2026
Our May 2026 scientific review compiles 30 publications on photobiomodulation, including several meta-analyses and randomized trials. Overview by clinical field: pain, supportive oncology, neurology, oral health, sports medicine, wound healing, and ophthalmology.
Read the article
Research & Innovation
PBM Research Update: 17 new publications in one week
17 scientific publications on photobiomodulation in one week: oncology, pain management, dermatology, neurology, and cellular mechanisms.
Read the article
Research & Innovation
Photobiomodulation Research Update - April 2026
As of April 2026, 144 PubMed publications on photobiomodulation had been indexed. Our team selected 18 notable clinical studies in the fields of neurology, supportive oncology, ophthalmology, dentistry, sports medicine, and pain management.
Read the article